Innovent Biologics Inc Financial Flexibility Index
Innovent Biologics Inc financial flexibility index. Innovent Biologics Inc (6IB) has a Financial Flexibility Index of 0.00x as of June 2023. Free cash flow of €-12.49 Million (operating CF €-311.45 Million minus capex €298.95 Million) represents 0% of total liabilities (€7.11 Billion). See cash generation quality of Innovent Biologics Inc to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Innovent Biologics Inc (2016–2025)
Financial flexibility index of Innovent Biologics Inc from 2016 to 2025. Historical Financial Flexibility Index trend for Innovent Biologics Inc across 10 annual periods. Check 6IB cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Innovent Biologics Inc Financial Flexibility Index by Year (2016–2025)
Innovent Biologics Inc financial flexibility index by year from 2016 to 2025. Year-by-year free cash flow to debt coverage for Innovent Biologics Inc. For the full cash flow conversion analysis, see Innovent Biologics Inc (6IB) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.59x | €10.68 Billion | €10.00 Billion | €17.99 Billion | ▲ +68.4% |
| 2024 | 0.35x | €2.99 Billion | €1.29 Billion | €8.48 Billion | ▲ +86.6% |
| 2023 | 0.19x | €1.53 Billion | €147.81 Million | €8.10 Billion | ▲ +341.4% |
| 2022 | -0.08x | €-537.07 Million | €-1.92 Billion | €6.86 Billion | ▲ +51.7% |
| 2021 | -0.16x | €-959.21 Million | €-2.02 Billion | €5.91 Billion | ▼ -373.3% |
| 2020 | 0.06x | €181.33 Million | €-307.69 Million | €3.06 Billion | ▲ +111.3% |
| 2019 | -0.52x | €-1.30 Billion | €-1.66 Billion | €2.47 Billion | ▼ -44.0% |
| 2018 | -0.36x | €-699.09 Million | €-1.01 Billion | €1.92 Billion | ▼ -270.5% |
| 2017 | -0.10x | €-401.30 Million | €-492.27 Million | €4.08 Billion | ▼ -21.9% |
| 2016 | -0.08x | €-304.55 Million | €-362.99 Million | €3.77 Billion | — |